{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:01:15Z","timestamp":1789912875120,"version":"4.0.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T00:00:00Z","timestamp":1332892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034347","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T21:13:03Z","timestamp":1332969183000},"page":"e34347","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia"],"prefix":"10.1371","volume":"7","author":[{"given":"Maher","family":"Hanoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewin","family":"Eisele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Greally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"H\u00fcttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semra","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Scholtysik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Klein-Hitpass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"D\u00fcrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/jnci\/93.20.1557","article-title":"Night shift work, light at night, and risk of breast cancer.","volume":"93","author":"S Davis","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4161\/cc.9.6.11046","article-title":"Circadian rhythms and cancer.","volume":"9","author":"S Gery","year":"2010","journal-title":"Cell Cycle"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.4161\/cc.6.11.4295","article-title":"Circadian clock and breast cancer: a molecular link.","volume":"6","author":"S Sahar","year":"2007","journal-title":"Cell Cycle"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc2747","article-title":"Metabolism and cancer: the circadian clock connection.","volume":"9","author":"S Sahar","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1158\/0008-5472.CAN-09-0648","article-title":"Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.","volume":"69","author":"Y Zhu","year":"2009","journal-title":"Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1158\/0008-5472.CAN-05-1119","article-title":"Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer.","volume":"65","author":"MA Gauger","year":"2005","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00428-009-0761-7","article-title":"Disturbance of circadian gene expression in breast cancer.","volume":"454","author":"SJ Kuo","year":"2009","journal-title":"Virchows Arch"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-0609.2009.01287.x","article-title":"Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia.","volume":"83","author":"L Eisele","year":"2009","journal-title":"Eur J Haematol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/sj.leu.2404363","article-title":"Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.","volume":"20","author":"A H\u00fcttmann","year":"2006","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/10428190802541807","article-title":"Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups.","volume":"50","author":"LE Jantus","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3324\/haematol.13052","article-title":"Cryptochrome-1 expression: a new prognostic marker in B-cell chronic lymphocytic leukemia.","volume":"94","author":"EJ Lewintre","year":"2009","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1101\/sqb.2007.72.015","article-title":"Structure and function of animal cryptochromes.","volume":"72","author":"N Ozturk","year":"2007","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1073\/pnas.0813028106","article-title":"Loss of cryptochrome reduces cancer risk in p53 mutant mice.","volume":"106","author":"N Ozturk","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.","volume":"111","author":"M Hallek","year":"2008","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.leu.2402339","article-title":"CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.","volume":"16","author":"J D\u00fcrig","year":"2002","journal-title":"Leukemia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/sj.leu.2403707","article-title":"Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.","volume":"19","author":"R Schroers","year":"2005","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/bioinformatics\/btp382","article-title":"A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry.","volume":"25","author":"RF Thompson","year":"2009","journal-title":"Bioinformatics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/bioinformatics\/bth069","article-title":"dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data.","volume":"20","author":"M Lin","year":"2004","journal-title":"Bioinformatics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/bioinformatics\/bth418","article-title":"Analysis of array CGH data: from signal ratio to gain and loss of DNA regions.","volume":"20","author":"P Hupe","year":"2004","journal-title":"Bioinformatics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0.","volume":"38","author":"M Reich","year":"2006","journal-title":"Nat Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cancergencyto.2010.09.002","article-title":"Gene dosage effects in chronic lymphocytic leukemia.","volume":"203","author":"L Sellmann","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/mc.20198","article-title":"Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR.","volume":"45","author":"MC Shih","year":"2006","journal-title":"Mol Carcinog"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2003-03-0779","article-title":"Circadian clock genes oscillate in human peripheral blood mononuclear cells.","volume":"102","author":"DB Boivin","year":"2003","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"34079","DOI":"10.1074\/jbc.R400016200","article-title":"Regulation of the mammalian circadian clock by cryptochrome.","volume":"279","author":"A Sancar","year":"2004","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4161\/epi.6.3.14038","article-title":"Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia.","volume":"6","author":"L Irving","year":"2011","journal-title":"Epigenetics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1182\/blood-2010-08-298968","article-title":"Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.","volume":"117","author":"C Olk-Batz","year":"2011","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.leu.2404802","article-title":"The role of prognostic factors in assessing \u2018high-risk\u2019 subgroups of patients with chronic lymphocytic leukemia.","volume":"21","author":"NE Kay","year":"2007","journal-title":"Leukemia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1200\/JCO.2004.12.133","article-title":"Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status.","volume":"22","author":"C Haslinger","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(02)00961-3","article-title":"The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo.","volume":"111","author":"L Fu","year":"2002","journal-title":"Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10552-005-9003-8","article-title":"Tumor suppression by the mammalian Period genes.","volume":"17","author":"CC Lee","year":"2006","journal-title":"Cancer Causes Control"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1534735409352083","article-title":"Circadian time-dependent tumor suppressor function of period genes.","volume":"8","author":"X Yang","year":"2009","journal-title":"Integr Cancer Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3109\/07420520903431301","article-title":"The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day.","volume":"26","author":"X Yang","year":"2009","journal-title":"Chronobiol Int"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1158\/0008-5472.CAN-08-4572","article-title":"Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2.","volume":"69","author":"AE Hoffman","year":"2009","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1158\/0008-5472.CAN-09-3798","article-title":"CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses.","volume":"70","author":"AE Hoffman","year":"2010","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e10995","DOI":"10.1371\/journal.pone.0010995","article-title":"Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice.","volume":"5","author":"S Lee","year":"2010","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature10649","article-title":"The circadian molecular clock creates epidermal stem cell heterogeneity.","volume":"480","author":"P Janich","year":"2011","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"14697","DOI":"10.1073\/pnas.260498597","article-title":"Functional redundancy of cryptochromes and classical photoreceptors for nonvisual ocular photoreception in mice.","volume":"97","author":"CP Selby","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"25891","DOI":"10.1074\/jbc.M111.254680","article-title":"Biochemical analysis of the canonical model for the mammalian circadian clock.","volume":"286","author":"R Ye","year":"2011","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1126\/science.1141194","article-title":"SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins.","volume":"316","author":"L Busino","year":"2007","journal-title":"Science"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T08:21:55Z","timestamp":1589012515000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034347"}},"subtitle":[],"editor":[{"given":"Osman","family":"El-Maarri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,28]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034347","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,28]]}}}